Lindbrook Capital, LLC Chimerix Inc Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$5.23 - $7.18 $75,285 - $103,356	-14,395 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$5.94 - $8.75 $8,910 - $13,125	1,500 Added 11.63%	14,395 $89,000
Q2 2021 Jul 27, 2021	BUY	$7.54 - $9.79 $37,700 - $48,949	5,000 Added 63.33%	12,895 $103,000
Q1 2021 Apr 28, 2021	BUY	$4.76 - $11.25 $6,640 - $15,693	1,395 Added 21.46%	7,895 $76,000
Q4 2020 Jan 27, 2021	BUY	$2.43 - $5.42 $15,795 - $35,230	6,500 New	6,500 $31,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.